Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Johnson Health Tech Co., Ltd. (1736:TWSE), powered by AI.
Johnson Health Tech Co., Ltd. is currently trading at $117.50. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Johnson Health Tech Co., Ltd. on Alpha Lenz.
Johnson Health Tech Co., Ltd.'s P/E ratio is 13.0.
“Johnson Health Tech Co., Ltd. trades at a P/E of 13.0 (undervalued) with strong ROE of 21.3%. 3Y revenue CAGR of 17.4% highlights clear growth momentum.”
Ask for details →Johnson Health Tech Co., Ltd. is a prominent global player in the fitness equipment manufacturing industry. Founded in 1975, the company specializes in the design, production, and distribution of a diverse range of fitness equipment, catering to both commercial and residential users. Its product lineup includes treadmills, ellipticals, exercise bikes, and strength-training machines, among others. The firm is renowned for combining quality and innovation, frequently integrating technology to enhance user experience and fitness metrics tracking. Headquartered in Taiwan, Johnson Health Tech has an extensive global footprint, with subsidiaries and service networks across Asia, Europe, and the Americas. The company plays a critical role in promoting health and wellness, influencing not only individual consumers but also gyms, health clubs, and wellness-focused enterprises. By continuously evolving its product offerings and maintaining a strong commitment to sustainable practices, Johnson Health Tech Co., Ltd. holds a significant position in the competitive fitness equipment sector worldwide.
“Johnson Health Tech Co., Ltd. trades at a P/E of 13.0 (undervalued) with strong ROE of 21.3%. 3Y revenue CAGR of 17.4% highlights clear growth momentum.”
Ask for details →Johnson Health Tech Co., Ltd. (ticker: 1736) is a company listed on TWSE in the Consumer Cyclical sector (Leisure). Market cap is $35.7B.
The current price is 117.5 with a P/E ratio of 12.97x and P/B of 2.6x.
ROE is 21.34% and operating margin is 6.75%. Annual revenue is $54.3B.